Xiao-Jian Zhou

4PUBLICATIONS
4CO-AUTHORS
Medical virologyPharmacogenomicsMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 25, 2026
Bemnifosbuvir: An HCV NS5B Inhibitor With Multiple Modes of Action.

|Mar 25, 2024
First-in-human trial evaluating safety and pharmacokinetics of AT-752, a novel nucleotide prodrug with pan-serotype activity against dengue virus.

Xiao-Jian Zhou, Jason Lickliter, Maureen Montrond

|Jan 24, 2024
Bemnifosbuvir (BEM, AT-527), a novel nucleotide analogue inhibitor of the hepatitis C virus NS5B polymerase.

Xiao-Jian Zhou, Steven S Good, Keith Pietropaolo

Pageof 1